Transcription of WHO GUIDE TO EFFECTIVENESS ANALYSIS
{{id}} {{{paragraph}}}
WHO GUIDE TOCOST- EFFECTIVENESS ANALYSISCONTENTSThe graphic on the cover is a stylized representation of Figure 5 inBackground Paper 7 showing uncertainty INHEALTH:WHO GUIDE TOCOST- EFFECTIVENESS ANALYSISEDITED BYT. TAN-TORRESEDEJER, R. BALTUSSEN, T. ADAM,R. HUTUBESSY, A. ACHARYA, EVANS MURRAYW orld Health OrganizationGenevaWHO Library Cataloguing-in-Publication DataWorld Health choices in health: WHO GUIDE to cost- EFFECTIVENESS ANALYSIS /edited by T. Tan-Torres Edejer .. [et al.]1. Cost-benefit ANALYSIS methods 2. Health care rationing economics3. Decision making4. Health priorities economics5. Models, Econometric6. GuidelinesI. Tan-Torres Edejer, WHO-CHOICE 92 4 154601 8(LC/NLM classification: HD ) World Health Organization 2003 All rights reserved. Publications of the World Health Organization can beobtained from Marketing and Dissemination, World HealthOrganization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +4122 791 2476; fax: +41 22 791 4857; email: for permission to reproduce or translate WHO publications whether for sale or for noncommercial distribution should be addressedto Publications, at the above address (fax: +4))
addressed in traditional CEA which typically evaluates new interventions in comparison with the current mix (intervention mix constrained CEA or IMC-CEA)—categorizes GCEA as a different, more fundamental, type of economic analysis. For many narrower applications of CEA, such as the appraisal of a new version of an existing drug in a specific ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}